Ampersand Biosciences
Ampersand Biosciences develops and manufactures Luminex multiplex immunoassay kits, antibodies, and recombinant proteins — with a specialty in underrepresented mammalian models (ferret, hamster, porcine, guinea pig) — serving pharmaceutical, biotech, and academic research laboratories through direct sales, sample testing services, and custom assay development.
- Company typePrivate
- Founded2015
- HeadquartersLake Clear, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Ampersand Biosciences does
Ampersand Biosciences is a privately held contract research organization and reagent manufacturer founded in 2015 and headquartered in Lake Clear, New York. The company develops and commercializes multiplex immunoassay kits, monoclonal and polyclonal antibodies, and recombinant proteins built primarily on the Luminex xMAP bead-based platform and ELISA, with species coverage spanning mouse, rat, hamster, ferret, canine, guinea pig, porcine, and human. Its primary technical differentiator is a focus on underrepresented mammalian models — notably ferret (Ferret MAP 1.0, 13-plex, first-to-market) and hamster (Hamster MAP 1.0, 9-plex, sole-source for COVID-19 response evaluation) — where validated reagents are otherwise scarce in the research tools market. Panels are validated for cross-reactivity, linearity, precision, and stability, with bridging studies between production lots to ensure reproducibility.
The company operates three revenue streams: (1) catalog product sales of Luminex kits, antibodies, and recombinant proteins through a direct e-commerce storefront and an international distributor network spanning Germany, UK, Europe, China, Japan, Singapore, and Italy; (2) fee-for-service sample testing under GLP protocols, priced between $60 and $400 per sample depending on species and assay complexity; and (3) custom assay development services, typically completed in 2–4 months, covering Luminex multiplex assay development, ELISA development, custom protein expression, and antibody development. Its customer base consists of pharmaceutical and biotech drug discovery teams and academic research laboratories, with the federal government (NIAID, CDC, DoD) acting as a meaningful funding counterparty through recurring SBIR awards and contracts, including a $600,000 NIAID contract awarded in June 2025.
Ampersand is a privately owned women business enterprise with 1–10 employees, no disclosed parent company, and no private equity or venture capital investment on record. Over 217 academic citations reference its products and services across infectious disease, oncology, and immunology research, providing third-party validation of its reagents. The company has received three consecutive SBIR awards from NIAID (2020, 2022, 2024) and is scheduled to exhibit at Immunology 2026, indicating sustained engagement with the academic and government research ecosystem.
Ampersand Biosciences firmographics
Firmographics- Name
- Ampersand Biosciences
- Legal name
- Ampersand Biosciences
- Website
- https://ampersandbio.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Ampersand Biosciences develops and manufactures Luminex multiplex immunoassay kits, antibodies, and recombinant proteins — with a specialty in underrepresented mammalian models (ferret, hamster, porcine, guinea pig) — serving pharmaceutical, biotech, and academic research laboratories through direct sales, sample testing services, and custom assay development.
- Ownership category
- akta.pro rank
Ampersand Biosciences industry classification
Industry- Product category
- Immunoassay Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
- akta.pro secondary industry
- Proteomics & Biomarker Analytical Testing (HLAGADAG)
Keywords
Where Ampersand Biosciences is headquartered
LocationHeadquarters
- HQ city
- Lake Clear
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Ampersand Biosciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain
Revenue model
- Luminex Kit and ELISA Product Sales: Sale of packaged Luminex Multiplex Cytokine Panels (available in standard well plate or 96 well plate format) and individual antibodies and recombinant proteins for Western Blot and ELISA testing. Products are validated with native samples and undergo rigorous validation prior to release. Includes species-specific panels for mouse, rat, hamster, ferret, canine, guinea pig, porcine, and human.
- Sample Testing Services: Fee-for-service biomarker sample testing using validated Luminex and ELISA protocols. Testing covers mouse, rat, hamster, ferret, canine, and human biomarker samples. Services follow GLP protocols and include purity, safety, potency, and yield testing. Pricing per sample ranges from $60 to $400 depending on species and assay complexity.
- Custom Assay Development: Custom assay development services including Luminex Multiplex Assay Development and ELISA development for application-specific solutions. Services include packaging and lyophilization, design control documentation, and sample testing. Offers three options: Custom Protein Expression (Mammalian or E. coli), Antibody Development, and Luminex xMAP-Based Kits and Assays. Projects typically completed in 2–4 months.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Mouse MAP 5.0 — 42-plex cytokine panel |
| Unit Pricing | Pay-as-you-go | Ferret MAP 1.0 — 13-plex cytokine panel |
| Unit Pricing | Pay-as-you-go | Canine MAP 1.0 — 15-plex cytokine panel |
| Unit Pricing | Pay-as-you-go | Hamster MAP 1.0 — 9-plex cytokine panel |
| Unit Pricing | Pay-as-you-go | Individual Monoclonal Antibodies |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Ampersand Biosciences product offering
Product offeringCore offering
Ampersand Biosciences develops, manufactures, and sells Luminex multiplex cytokine panels, monoclonal and polyclonal antibodies, and recombinant proteins for biomarker analysis across multiple species (mouse, rat, hamster, ferret, canine, porcine, guinea pig, human). The company also provides fee-for-service sample testing and custom immunoassay/ELISA development at its GLP-compliant laboratory in Lake Clear, NY, with a specialized focus on reagents for underrepresented mammalian models used in infectious disease research.
Product overview
Ampersand Biosciences offers customized immunoassay kits and testing services focused on biomarker analysis for drug discovery. The company's product portfolio centers on Luminex Multiplex Cytokine Panels and Sample Testing Services across multiple species (mouse, rat, hamster, canine, ferret, porcine, guinea pig, and human). Key offerings include the Mouse MAP 5.0 (detecting 42 cytokines), Ferret MAP 1.0 (first-to-market ferret cytokine panels), Hamster MAP 1.0 (only available hamster panels for COVID response), and species-specific MAP panels. The company also provides Assay Development Services including custom Luminex and ELISA development, custom protein expression, and antibody development. Products include monoclonal and polyclonal antibodies, recombinant proteins, and specialized Luminex kits like the Human/Mouse Flavivirus Serological Panel. Services follow GLP standards and include sample testing, tissue homogenate preparation, and experiment execution at their secure facility in northern New York.
Differentiator
Problem solved
Functional benefit
Products and services
- Luminex Multiplex Cytokine Panels Multiplex immunoassay kits for quantitative measurement of cytokines and growth factors using the Luminex xMAP platform, available in standard or 96-well plate formats across mouse, rat, hamster, ferret, canine, porcine, guinea pig, and human species.
- Mouse MAP 5.0 High-plex multiplex immunoassay service detecting 42 cytokines and growth factors from small sample volumes for mouse biomarker testing.
- Hamster MAP 1.0 Multiplex immunoassay service detecting 9 cytokines and growth factors in hamster samples, the only hamster cytokine panel available for COVID response evaluation.
- Canine MAP 1.0 Multiplex immunoassay service detecting 15 cytokines and growth factors using canine-specific standards and antibodies validated on the Luminex platform.
- Ferret MAP 1.0 First-to-market ferret cytokine panel providing 13 cytokines and growth factors for evaluating immune response to influenza and respiratory diseases.
- Rat MAP 2.0 Multiplex immunoassay service for rat biomarker testing on the Luminex platform, supplemented by 13-plex High Sensitivity and 11-plex Cytokine-Chemokine kits.
- Porcine MAP 1.0 Multiplex immunoassay service detecting 9 cytokines and growth factors for porcine biomarker testing on the Luminex platform.
- Guinea Pig MAP 1.0 Multiplex immunoassay service for guinea pig biomarker testing using the Luminex platform.
- Human MAPs Multiplex immunoassay services for human biomarker testing using the Luminex platform.
- Custom Assay Development Services Custom Luminex Multiplex Assay Development and ELISA development for application-specific solutions, including custom protein expression (mammalian or E. coli), antibody development, and Luminex xMAP-based kits and assays. Typical project completion in 2–4 months.
- Sample Testing Services Fee-for-service biomarker sample testing using validated Luminex, ELISA, Western Blot, and Immunoprecipitation methods under GLP protocols for mouse, rat, hamster, ferret, canine, porcine, and human samples. Pricing $60–$400 per sample depending on species and assay complexity.
- Monoclonal Antibodies In-house developed and validated monoclonal antibodies tested with native samples and rigorously validated for multiple species including human, hamster, ferret, rat, and mouse. Targets include cytokines (IL-2, IL-4, IL-6, IL-17, IFNγ), immune markers (CD25, CD69, CD64), and other proteins. Standard unconjugated: $350; biotin-conjugated: $375.
- Polyclonal Antibodies Validated polyclonal antibodies for research applications including ELISA, Western Blot, and Immunoprecipitation, tested with native samples and validated prior to release.
- Recombinant Proteins Recombinant proteins available for Western Blot and ELISA antibody assay testing across multiple species.
- Human/Mouse Flavivirus Serological Luminex Panel 14-plex Luminex Flavivirus IgG Panel for Human and Mouse Reactivity covering Zika Virus, Chikungunya Virus, Dengue Virus, Yellow Fever Virus, Japanese Encephalitis Virus, St. Louis Encephalitis Virus, Equine Encephalitis Virus, and West Nile Virus.
Quantifiable outcome
- Custom assay development projects completed in 2–4 months
- +1 more outcomes
Companies that use Ampersand Biosciences
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Ampersand Biosciences technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Ampersand Biosciences partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core.
- BIOZOL GmbHcoreBIOZOL GmbH is a trusted international distributor of Ampersand Biosciences products in Germany. BIOZOL has decades of experience within biosciences and a top-notch reputation for efficiency in supplying high-quality research and diagnostics products.
- 2BScientific Ltdcore2BScientific Ltd is a trusted international distributor of Ampersand Biosciences products in the United Kingdom. The company has decades of experience within biosciences and a top-notch reputation for efficiency in supplying high-quality research and diagnostics products.
- 2BScientific GmbHcore2BScientific GmbH is a trusted international distributor of Ampersand Biosciences products in Europe. The company has decades of experience within biosciences and a top-notch reputation for efficiency in supplying high-quality research and diagnostics products.
- Dakewe BiotechcoreDakewe Biotech is a trusted international distributor of Ampersand Biosciences products in China. The company has decades of experience within biosciences and a top-notch reputation for efficiency in supplying high-quality research and diagnostics products.
- ASONEcoreASONE is a trusted international distributor of Ampersand Biosciences products in Japan. The company has decades of experience within biosciences and a top-notch reputation for efficiency in supplying high-quality research and diagnostics products.
- Omnicell Pte LtdcoreOmnicell Pte Ltd is a trusted international distributor of Ampersand Biosciences products in Singapore. The company has decades of experience within biosciences and a top-notch reputation for efficiency in supplying high-quality research and diagnostics products.
- Labospace srlcoreLabospace srl is a trusted international distributor of Ampersand Biosciences products in Italy. The company has decades of experience within biosciences and a top-notch reputation for efficiency in supplying high-quality research and diagnostics products.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Ampersand Biosciences competitors and assessment
Company assessmentEmerging players
- Olink: Olink offers proximity extension assay-based biomarker discovery platforms targeting pharma and academic customers similar to Ampersand's. It focuses on high-multiplex proteomics rather than classical Luminex, representing a complementary emerging platform.
- Quanterix: Quanterix provides ultra-sensitive single-molecule biomarker detection assays (Simoa) used for translational research in pharma and academic labs. It targets a similar biomarker customer base to Ampersand and competes for multiplex biomarker spend.
Broad incumbents
- GenScript: GenScript offers custom antibody development, recombinant protein expression, and ELISA/Luminex assay services that directly overlap with Ampersand's custom assay development and protein expression offerings. It operates at significantly larger scale globally.
- Bio-Techne: Bio-Techne (R&D Systems, Novus Biologicals, Tocris) is one of the largest suppliers of cytokine antibodies, ELISA kits, and Luminex multiplex panels across mouse, rat, and human. It is the closest large-scale catalog peer to Ampersand's immunoassay reagent business, though it does not specialize in underrepresented species like ferret or hamster.
- Thermo Fisher Scientific: Thermo Fisher (Invitrogen, eBioscience, Pierce) is a global life sciences tools incumbent with extensive immunoassay reagents, Luminex multiplex panels, antibodies, and custom assay services. It competes with Ampersand across nearly the full catalog and on custom assay development at pharma customers.
- Millipore Sigma: Millipore Sigma (Sigma-Aldrich, Millipore) offers a broad catalog of antibodies, ELISA kits, and multiplex assay reagents serving academic and pharma research. It competes directly with Ampersand in Luminex multiplex offerings and general immunoassay reagents across most of Ampersand's species panel.
Direct peers
- Meso Scale Diagnostics (MSD): MSD operates an electrochemiluminescence-based multiplex biomarker platform directly competitive with Luminex xMAP used by Ampersand. It sells validated multiplex cytokine and biomarker panels and custom assay services to the same pharma and academic customers Ampersand targets.
- Abcam: Abcam is a leading antibody and reagent supplier with a strong catalog of validated antibodies and immunoassay tools across multiple species. It directly overlaps with Ampersand's antibody, recombinant protein, and Luminex kit catalog.
- Cayman Chemical: Cayman Chemical is a privately held research reagent supplier offering immunoassay kits, antibodies, and ELISA/multiplex reagents across multiple species. It is comparable to Ampersand as a privately held specialty immunoassay reagent provider serving academic and translational research customers.
- Luminex Corporation (DiaSorin): Luminex (now part of DiaSorin) developed the xMAP bead-based multiplex platform Ampersand uses and also sells its own MILLIPLEX kits and reagents. It is both a platform enabler and a direct catalog competitor in Luminex-based multiplex immunoassays.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Ampersand Biosciences social profiles
Digital presenceAmpersand Biosciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ampersand Biosciences leadership team
Management profileNumber of profiles
Ampersand Biosciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ampersand Biosciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ampersand Biosciences
What does Ampersand Biosciences do?
Ampersand Biosciences develops, manufactures, and sells Luminex multiplex cytokine panels, monoclonal and polyclonal antibodies, and recombinant proteins for biomarker analysis across multiple species (mouse, rat, hamster, ferret, canine, porcine, guinea pig, human). The company also provides fee-for-service sample testing and custom immunoassay/ELISA development at its GLP-compliant laboratory in Lake Clear, NY, with a specialized focus on reagents for underrepresented mammalian models used in infectious disease research.
Is Ampersand Biosciences a public or private company?
Ampersand Biosciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Ampersand Biosciences founded?
Ampersand Biosciences was founded in 2015. It employs 1 to 10 people.
Where is Ampersand Biosciences based?
Ampersand Biosciences is headquartered in Lake Clear, United States, in the North America region.
How does Ampersand Biosciences make money?
Three revenue lines are on record. Luminex Kit and ELISA Product Sales are the primary driver. The others are sample Testing Services and custom Assay Development.
Who are Ampersand Biosciences's main competitors?
Emerging players on record are Olink and Quanterix. Broad incumbents are GenScript, Bio-Techne, Thermo Fisher Scientific and Millipore Sigma. Direct peers are Meso Scale Diagnostics (MSD), Abcam, Cayman Chemical and Luminex Corporation (DiaSorin).
Does Ampersand Biosciences have an API?
No public API is recorded for Ampersand Biosciences.
What industry is Ampersand Biosciences in?
Ampersand Biosciences's product category is Immunoassay Reagents. Its primary akta.pro industry code is HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls), with a secondary code of HLAGADAG, Proteomics & Biomarker Analytical Testing. Its NAICS code is 325413 and its SIC code is 2835.